RNA Therapeutics
Part of Healthcare - Genomics & Precision Medicine
 ALNY | Alnylam Pharmaceuticals, Inc. | $27.5b | $239.26 | +1.7% | 1.2M |
 ARWR | Arrowhead Research Corporation | $11.9b | $88.86 | +2.4% | 686.2K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | $8.6b | $63.80 | +2.4% | 2.1M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | $1.1b | $5.23 | +2.7% | 1.9M |
 PRQR | ProQR Therapeutics N.V. Ordinary Shares | $241.3m | $2.35 | -2.3% | 2.2M |
 RNAC | Cartesian Therapeutics, Inc. Common Stock | $231.2m | $10.36 | +3.1% | 81.6K |
 RNA | Atrium Therapeutics, Inc. Common Stock | $193.8m | $13.97 | +2.6% | 153.2K |
 CAMP | CAMP4 Therapeutics Corporation Common Stock | $179.1m | $4.45 | +3.0% | 166.9K |
 PHIO | Phio Pharmaceuticals Corp. Common Stock | $12.0m | $1.19 | +2.6% | 268.6K |
 XCUR | Exicure, Inc. Common Stock | $10.1m | $1.21 | 0.0% | 18.1K |